Mutations in the KIT gene, encoding receptor tyrosine kinase c-KIT, are typically found in acral and mucosal melanomas [56,57] and may be predicted to activate a PAK1-mediated oncogenic pathway, as was documented in other malignancies [58]. Here, KIT is linked to melanoma.